Core Viewpoint - The appointment of Mr. Lu Ying as the Chief Financial Officer of Weisheng Pharmaceutical-B (02561.HK) is a strategic move aimed at enhancing the company's financial management and investor relations capabilities [3]. Group 1: Appointment Details - Weisheng Pharmaceutical-B announced the appointment of Mr. Lu Ying as CFO effective from October 13, 2025 [3]. - Mr. Lu Ying, aged 41, has over 19 years of financial management experience [3]. Group 2: Previous Experience - Prior to joining Weisheng Pharmaceutical, Mr. Lu served as CFO at Weimou Biotechnology (Zhejiang) Co., Ltd. from August 2021 to October 2025, focusing on corporate financing and investor relations [3]. - He held the position of Financial Director at Allergan Information Consulting (Shanghai) Co., Ltd. from August 2020 to August 2021, overseeing financial management and strategic planning [3]. - Mr. Lu worked at Bayer A.G. in various financial management roles from September 2010 to August 2020, with his last position being CFO of Bayer Healthcare, responsible for overall financial management in Hong Kong [3]. - Earlier in his career, he was a Senior Accountant at PwC from August 2006 to February 2010 [3]. Group 3: Educational Background - Mr. Lu obtained a Bachelor's degree in Economic and Trade English from Shanghai University of Finance and Economics in June 2006 [3].
围观！某港股公司聘任普华永道背景CFO！